AGTR2 and obesity disorder: In fact, chronic treatment with the AT2 agonist (Compound 21) has been shown to reduce the size of hypertrophied adipocytes and WAT mass in rodents fed a high-fat diet, suggesting the favorable effects of AT2 activation for the treatment of obesity [77].